Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-2 mycotoxin is a type A trichothecene produced by Fusarium species that contaminates grains such as wheat, barley, and oats. Its toxicity is largely attributed to the 12,13-epoxy ring and high-affinity binding to the peptidyl transferase center of the 60S ribosomal subunit, blocking polypeptide chain initiation and thereby inhibiting protein synthesis; it also inhibits DNA and RNA synthesis, perturbs membrane phospholipid metabolism, induces oxidative stress, and triggers apoptosis in rapidly dividing tissues (GI mucosa, bone marrow, immune cells). Exposure causes acute and systemic toxicosis across dermal, inhalational, and gastrointestinal routes with symptoms ranging from local irritation/necrosis to systemic weakness, ataxia, GI distress, respiratory effects, and cardiovascular collapse; late effects include cytopenias due to bone marrow suppression. In the liver, T-2 reduces microsomal CYP activities and causes hepatotoxicity with elevated ALT/AST/ALP and reduced total protein; oxidative stress is a central mechanism, and selenium/selenomethionine can mitigate injury by supporting antioxidant enzymes such as glutathione peroxidase and thioredoxin reductase. T-2 is nonvolatile, environmentally stable, and undergoes biotransformation (notably to HT-2) in vivo.
Binds the peptidyl transferase center of the 60S ribosomal subunit to inhibit protein synthesis; Inhibits DNA and RNA synthesis; Induces oxidative stress and activates stress MAPKs (e.g., JNK/p38); Alters membrane phospholipid metabolism; Inhibits monoamine oxidase activity; Disrupts mitochondrial respiration
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-2 mycotoxin (T-2 toxin).